04:28 AM EDT, 05/31/2024 (MT Newswires) -- Gyre Therapeutics ( GYRE ) said late Thursday that the Chinese National Medical Products Administration approved its subsidiary Gyre Pharmaceuticals' investigational new drug application for F230, its therapeutic candidate for pulmonary arterial hypertension. In preclinical studies, F230 showed significant decreases in mean pulmonary arterial pressure, right ventricular systolic pressure, right ventricular/left ventricular plus...

04:35 AM EDT, 05/31/2024 (MT Newswires) -- AbbVie ( ABBV ) said Friday that the European Medicines Agency's advisory committee recommended approval of risankizumab for treating adults with moderately to severely active ulcerative colitis who have not responded adequately to conventional or biologic therapy. The Committee for Medical Products for Human Use's recommendation was based on two phase 2 trials,...

04:32 AM EDT, 05/31/2024 (MT Newswires) -- Orrstown Financial Services ( ORRF ) and Codorus Valley Bancorp ( CVLY ) said late Thursday both companies have received shareholder approval for their planned merger. Orrstown shareholders also approved the issuance of shares of Orrstown common stock to Codorus Valley shareholders. The merger will likely close in Q3. ...

04:20 AM EDT, 05/31/2024 (MT Newswires) -- STMicroelectronics ( STM ) said Friday it plans to build the world's first fully integrated silicon carbide facility in Catania, Italy. The 5 billion euros ($5.41 billion) factory, which includes 2 billion euros in support by the government of Italy, will produce up to 15,000 200mm silicon carbide wafers for various semiconductors per...